The Cigna Group (NYSE:CI – Get Free Report) insider Nicole S. Jones sold 4,904 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the transaction, the insider now directly owns 29,421 shares in the company, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
The Cigna Group Trading Up 1.8 %
Shares of The Cigna Group stock opened at $315.54 on Friday. The company’s fifty day simple moving average is $291.99 and its 200-day simple moving average is $318.03. The company has a market cap of $87.77 billion, a price-to-earnings ratio of 25.78, a PEG ratio of 0.98 and a beta of 0.54. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83.
The Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the company posted $6.79 EPS. As a group, sell-side analysts expect that The Cigna Group will post 29.77 EPS for the current year.
The Cigna Group Increases Dividend
Analysts Set New Price Targets
CI has been the topic of several recent research reports. UBS Group cut their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. StockNews.com upgraded The Cigna Group from a “hold” rating to a “buy” rating in a report on Wednesday, February 19th. Sanford C. Bernstein downgraded The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a report on Thursday, February 6th. Barclays lowered their price target on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Finally, Piper Sandler reiterated an “overweight” rating and set a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $372.31.
View Our Latest Research Report on CI
Institutional Investors Weigh In On The Cigna Group
A number of institutional investors have recently bought and sold shares of CI. Adero Partners LLC raised its holdings in The Cigna Group by 4.5% during the 3rd quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after purchasing an additional 34 shares during the last quarter. CreativeOne Wealth LLC raised its holdings in The Cigna Group by 3.0% during the 3rd quarter. CreativeOne Wealth LLC now owns 1,219 shares of the health services provider’s stock worth $422,000 after purchasing an additional 35 shares during the last quarter. Kesler Norman & Wride LLC raised its holdings in The Cigna Group by 1.8% during the 4th quarter. Kesler Norman & Wride LLC now owns 2,033 shares of the health services provider’s stock worth $562,000 after purchasing an additional 35 shares during the last quarter. Hudson Edge Investment Partners Inc. raised its holdings in The Cigna Group by 1.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider’s stock worth $520,000 after purchasing an additional 36 shares during the last quarter. Finally, Meridian Wealth Management LLC raised its holdings in The Cigna Group by 1.0% during the 4th quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider’s stock worth $1,013,000 after purchasing an additional 37 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than The Cigna Group
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Most active stocks: Dollar volume vs share volume
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.